VELIPARIB for Ovarian epithelial cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 97 adverse event reports in the FDA FAERS database where VELIPARIB was used for Ovarian epithelial cancer.

Most Reported Side Effects for VELIPARIB

Side Effect	Reports	%	Deaths	Hosp.
Neutrophil count decreased	124	31.7%	7	67
Anaemia	118	30.2%	6	63
White blood cell count decreased	94	24.0%	6	53
Febrile neutropenia	76	19.4%	0	69
Platelet count decreased	70	17.9%	6	37
Hypertension	57	14.6%	3	33
Nausea	46	11.8%	2	38
Hyponatraemia	38	9.7%	4	22
Vomiting	36	9.2%	1	30
Hypokalaemia	31	7.9%	3	25
Dehydration	29	7.4%	4	25
Abdominal pain	24	6.1%	1	23
Diarrhoea	23	5.9%	1	20
Fatigue	23	5.9%	0	16
Embolism	19	4.9%	1	13